Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOUNDS AS SARS-COV-2 INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2023/165459
Kind Code:
A1
Abstract:
Provided are certain antiviral agents, pharmaceutical compositions thereof, and methods of use thereof.

Inventors:
HE CHENGXI (CN)
XU HUA (CN)
LIU QIHONG (CN)
LIU BIN (CN)
QI YANGLI (CN)
ZHOU ZUWEN (CN)
TAN RUI (CN)
HUANG ZHUO (CN)
TAN HAOHAN (CN)
CHEN ZHIFANG (CN)
LI ZHIFU (CN)
WANG YUNLING (CN)
CHEN LING (CN)
WANG XIANLONG (CN)
YANG LIJUN (CN)
DONG WENJING (CN)
LIN SHU (US)
ZHAO XINGDONG (CN)
WANG WEIBO (US)
Application Number:
PCT/CN2023/078655
Publication Date:
September 07, 2023
Filing Date:
February 28, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
FOCHON BIOSCIENCES LTD (CN)
International Classes:
C07D403/14; A61K31/513; A61K31/53; A61P31/12; C07D419/14
Foreign References:
CN114805316A2022-07-29
CN115038696A2022-09-09
CN114539228A2022-05-27
CN114507221A2022-05-17
Other References:
UNOH YUTO, UNOH YUTO, UEHARA SHOTA, NAKAHARA KENJI, NOBORI HARUAKI, YAMATSU YUKIKO, YAMAMOTO SHIHO, MARUYAMA YUKI, TAODA YOSHIYUKI: "Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 65, no. 9, 12 May 2022 (2022-05-12), US , pages 6499 - 6512, XP093007183, ISSN: 0022-2623, DOI: 10.1021/acs.jmedchem.2c00117
Attorney, Agent or Firm:
NTD UNIVATION INTELLECTUAL PROPERTY AGENCY LTD. (CN)
Download PDF: